Advertisement

Topics

Latest "Valeant Surges Post Reassessment" News Stories

00:29 EST 17th January 2019 | BioPortfolio

Here are the most relevant search results for "Valeant Surges Post Reassessment" found in our extensive news archives from over 250 global news sources.

More Information about Valeant Surges Post Reassessment on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Valeant Surges Post Reassessment for you to read. Along with our medical data and news we also list Valeant Surges Post Reassessment Clinical Trials, which are updated daily. BioPortfolio also has a large database of Valeant Surges Post Reassessment Companies for you to search.

Showing "Valeant Surges Post Reassessment" News Articles 1–25 of 7,600+

Wednesday 16th January 2019

The Future of FDA's Electronic Safety Surveillance

NewsThe Sentinel System is now a core feature of FDA's post-market safety surveillance armamentarium. Contributed Author: 


The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates

In this webinar we will discuss the process involved in a typical molecular pathology laboratory. The post The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates appeared first on GEN - Genetic Engineering and Biotechnology News.

Streamlined Formulation of Enzyme Products

In this webinar we will discuss the process involved in a typical molecular pathology laboratory. The post Streamlined Formulation of Enzyme Products appeared first on GEN - Genetic Engineering and Biotechnology News.


Viveve Reports Preliminary Full Year 2018 Financial Results

Viveve Medical (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today reported preliminary financial results for the full year ended December 31, 2018 and provided revenue guidance for 2019. As quoted in the press release: Estimated total revenue from the sale of 57 Viveve Systems worldwide, approximately 4,600 disposable treatment tips and other … Contin...

Microbot Medical Announces $5.9 Million Registered Direct Offering Priced At-the-Market

Microbot Medical (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with several institutional investors for the purchase of 590,000 shares of its common stock, at a purchase price per share of $10.00, in a registered direct offering priced at-the-...

Losartan could improve ovarian cancer treatment

Researchers have found that losartan could be beneficial for those undergoing cancer treatment as it may enhance its effectiveness... The post Losartan could improve ovarian cancer treatment appeared first on European Pharmaceutical Review.

Boston Children’s Hospital and Medumo Announce Strategic Collaboration to Help Patients Navigate their Care Journeys

Boston Children’s Hospital (BCH), the #1 ranked pediatric hospital based on US News and World Report, and Medumo, a leading patient navigation platform, are excited to announce they are teaming up to deliver a targeted pediatric care messaging service to improve access and patient experience. Loss-to-follow-up, missed appointments, and improper procedure...

FDA announces new policies for cell and gene therapies

Despite most of the US Food and Drug Administration’s (FDA) responsibilities grinding to a halt as a result of the...Read More... The post FDA announces new policies for cell and gene therapies appeared first on Pharmaceutical Technology.

Global Ophthalmic Ultrasound Devices Market 2019-2023 | Technological Advances in Ophthalmic Ultrasound Devices to Boost Growth | Technavio

The global ophthalmic ultrasound devices market is expected to post a CAGR of over 6% during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190116005384/en/

IBM & MineHub blockchain platform to track minerals in supply chain

IT giant IBM and tech firm MineHub Technologies have partnered to use blockchain technology to track high-value minerals across the...Read More... The post IBM & MineHub blockchain platform to track minerals in supply chain appeared first on Pharmaceutical Technology.

Global Hypodermic Needles Market 2019-2023 | Introduction of User-Friendly Features in Hypodermic Needles to Boost Growth | Technavio

The global hypodermic needles market is expected to post a CAGR close to 7% during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190116005348/en/

Neurons Grown in the Lab Strikingly Similar to Brain Cells

A critical component to advancing drug discovery for neurological diseases is obtaining neurons that can be used in research. Because human neurons can be hard to come by, alternative methods for creating them is an important area of study. Additionally, creating patient specific neurons is a cornerstone of the future of personalized medicine. A team […] The post Neurons Grown in the Lab Str...

Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II Failure

Aptinyx said today it will weigh its next steps in developing its lead candidate NYX-2925 after it failed a Phase II trial in people with painful diabetic peripheral neuropathy (DPN)—news that caused the company’s stock to lose more than two-thirds of its value in premarket trading. The company acknowledged that NYX-2925 missed its primary endpoint […] The post Aptinyx Weighs Lead Candid...

CRISPR Aids Fight Against Neglected Tropical Diseases

As a whole, parasitic diseases affect an exorbitant number of people worldwide but are often overlooked as they are rare in more developed regions. Additionally, many of these neglected diseases have unusual pathology, making them incredibly difficult to manage therapeutically. Yet now, an international team of investigators led by scientists at George Washington University (GW) […] The post...

Global Dental Braces Market 2019-2023| Rising Technological Advances to Boost Growth| Technavio

The global dental braces market is expected to post a CAGR close to 8% during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190116005420/en/

The Falsified Medicines Directive: steps to compliance 

As the date of implementing the FMD comes closer, organisations need to be ensuring compliance, whether in the EU or even after a possible no-deal Brexit... The post The Falsified Medicines Directive: steps to compliance  appeared first on European Pharmaceutical Review.

Endocrine-Disrupting Chemical Found in Store Receipts

A study headed by researchers at the University of Granada in Spain found that the vast majority of thermal paper-type shop receipts tested in Spain and Brazil and half of a sample of French receipts contained BPA Bisphenol A (BPA) a mass-produced chemical that has well-recognized endocrine-disrupting properties. The researchers, reporting in Environmental Research, say […] The post Endocrin...

ALS Researchers Discover New Biomarker and Drug Target

A research team led by scientists at Harvard University has found a potential new biomarker and drug target for amyotrophic lateral sclerosis (ALS). The study relied on stem cell models of human motor neurons to reveal the gene STMN2 as a potential therapeutic target. The post ALS Researchers Discover New Biomarker and Drug Target appeared first on GEN - Genetic Engineering and Biotechnology News.

Potential New Biomarker and Drug Target Found for ALS

A research team led by scientists at Harvard University said it has found a potential new biomarker and drug target for amyotrophic lateral sclerosis (ALS). Published in Nature Neuroscience, the study (“ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair”) relied on stem cell models of human motor neurons to reveal […] The post Potential...

Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the “Company” or “Kalytera”) is pleased to announced the closing of its previously announced private placement of 11,532,000 common shares of the Company and 11,532,000 common share purchase warrants for aggregate gross proceeds of C$605,430. Alere Financial Partners, a division of Cova Capital Partners LLC, acted as agent in the offeri...

Trice Medical closes $18.3m series C extension financing round

This round was led by Charter Capital Partners of Grand Rapids, Michigan and the Municipal Employees’ Retirement System (MERS) of Michigan. Other investors in Trice include Safeguard Scientifics, The post Trice Medical closes $18.3m series C extension financing round appeared first on Compelo Medical Devices.

Healeon introduces potent platelet-rich plasma series

In response to the requests of their customers for a more versatile and higher volume product, Healeon has developed a PRP solution that is the best available answer The post Healeon introduces potent platelet-rich plasma series appeared first on Compelo Medical Devices.

ALK paediatric SLIT-tablet trial meets primary endpoint

ALK has announced positive results from a Phase III paediatric clinical trial of its sublingual allergy immunotherapy (SLIT) tablet to...Read More... The post ALK paediatric SLIT-tablet trial meets primary endpoint appeared first on Drug Development Technology.

EpiVario Secures Exclusive Worldwide License for Novel Technologies and Drugs for Memory-Related Psychiatric Diseases from University of Pennsylvania

Company acquires full rights, in all fields, for novel drug to treat memory-related psychiatric disorders, such as post-traumatic stress disorder (PTSD) PHILADELPHIA (PRWEB) January 16, 2019 EpiVario, an early-stage drug discovery and development company, today announced it has secured an exclusive worldwide license, in all fields, for novel technologies and drug candidates for a wide range of me...

Pharma industry ‘call for action’ following Brexit vote

The pharma industry has called for the government to act to ensure that patients receive their medications in the case of a ‘no deal’ situation... The post Pharma industry ‘call for action’ following Brexit vote appeared first on European Pharmaceutical Review.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks